1. Norrving B. Long-term prognosis after lacunar infarction.
Lancet Neurol. 2003;2:238-245.
2. Regenhardt RW, Das AS, Lo EH, Caplan LR. Advances in understanding the pathophysiology of lacunar stroke: a review.
JAMA Neurol. 2018;75:1273-1281.
3. Del Bene A, Palumbo V, Lamassa M, Saia V, Piccardi B, Inzitari D. Progressive lacunar stroke: review of mechanisms, prognostic features, and putative treatments.
Int J Stroke. 2012;7:321-329.
4. Fisher CM. The arterial lesions underlying lacunes.
Acta Neuropathol. 1968;12:1-15.
5. Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept.
Neurology. 1989;39:1246-1250.
6. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance.
Circulation. 2007;115:1285-1295.
7. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier.
Nat Rev Neurosci. 2006;7:41-53.
8. Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Muñoz Maniega S, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction.
Ann Neurol. 2009;65:194-202.
9. Deplanque D, Lavallee PC, Labreuche J, Gongora-Rivera F, Jaramillo A, Brenner D, et al. Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a case-control study.
Int J Stroke. 2013;8:413-421.
10. Molina C, Sabín JA, Montaner J, Rovira A, Abilleira S, Codina A. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: a case-control study.
Stroke. 1999;30:2296-2301.
11. Knottnerus IL, Ten Cate H, Lodder J, Kessels F, van Oostenbrugge RJ. Endothelial dysfunction in lacunar stroke: a systematic review.
Cerebrovasc Dis. 2009;27:519-526.
12. Stevenson SF, Doubal FN, Shuler K, Wardlaw JM. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls.
Stroke. 2010;41:e434-e442.
13. Lee MJ, Park BY, Cho S, Park H, Chung CS. Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine.
Neurology. 2019;92:e342-e350.
14. Lee MJ, Cha J, Choi HA, Woo SY, Kim S, Wang SJ, et al. Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome: implications for pathophysiology and diagnosis.
Ann Neurol. 2017;81:454-466.
15. Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, Martin-Schild S. What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?
J Stroke Cerebrovasc Dis. 2013;22:675-682.
16. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke.
Ann Neurol. 2005;58:688-697.
17. Benarroch EE, Daube JR, Flemming KD, Westmoreland BF. Mayo clinic medical neuroscience: organized by neurologic systems and levels. 5th ed. Rochester: Mayo Foundation for Medical Education and Research; 2008. p. 462-469.
18. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Nature. 1980;288:373-376.
19. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
Circulation. 2006;113:1708-1714.
20. Jeong HG, Kim BJ, Yang MH, Han MK, Bae HJ. Neuroimaging markers for early neurologic deterioration in single small subcortical infarction.
Stroke. 2015;46:687-691.
21. Poppe AY, Coutts SB, Kosior J, Hill MD, O’Reilly CM, Demchuk AM. Normal magnetic resonance perfusion-weighted imaging in lacunar infarcts predicts a low risk of early deterioration.
Cerebrovasc Dis. 2009;28:151-156.
22. Liu P, De Vis JB, Lu H. Cerebrovascular reactivity (CVR) MRI with CO
2 challenge: a technical review.
Neuroimage. 2019;187:104-115.